Used as a potent inhibitor in targeted cancer therapies, particularly in the development of kinase inhibitors for treating various types of tumors. It shows significant activity against tyrosine kinases involved in cell proliferation and survival pathways, making it valuable in oncology research. Its structure allows for strong binding affinity and selectivity, which enhances efficacy while reducing off-target effects. Commonly employed in preclinical studies to evaluate antitumor activity and pharmacokinetic profiles in novel drug formulations.